Skip to main content

Want a detailed portfolio tracker?

Arvinas (ARVN) P/E (2018 - 2026)

Arvinas (ARVN) P/E from Oct 1, 2018 to Jul 21, 2026. The TTM Arvinas (ARVN) P/E is -2.51. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Arvinas (ARVN)

YearP/EChange
2026-2.51-73.35%
2025-9.43+42.71%
2024-6.61-11.65%
2023-7.48+3.90%
2022-7.20-67.12%
2021-21.89-26.86%
2020-29.93+51.92%
2019-19.70+150.48%
2018-7.87N/A

Comparison Arvinas (ARVN) P/E with competitors

Arvinas (ARVN) P/E is -2.51.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.07%
NBYStablecoin Development Corp0.00-100.17%
ENLVEnlivex Ltd0.07-102.98%
FGENFibroGen Inc0.24-109.55%
CHRSCoherus Biosciences Inc0.85-133.76%
FBIOFortress Biotech Inc0.95-137.76%
ORMPOramed Pharmaceuticals Inc1.50-159.80%
AGENAgenus Inc3.01-219.73%
INVAInnoviva Inc3.15-225.48%
VXRTVaxart Inc3.55-241.22%
CRMDCorMedix Inc3.63-244.35%
CVACCureVac N.V.4.45-276.87%
GLPGGalapagos NV4.86-293.31%
SRPTSarepta Therapeutics Inc4.88-294.23%
ABEOAbeona Therapeutics Inc5.39-314.34%
ABUSArbutus Biopharma Corp5.60-322.61%
ZVRAZevra Therapeutics Inc5.89-334.22%
SPROSpero Therapeutics Inc6.23-347.79%
CGENCompugen Ltd6.31-351.19%
RIGLRigel Pharmaceuticals6.87-373.40%
SLXNSilexion Therapeutics Corp7.30-390.27%
OMEROmeros Corporation9.26-468.35%
AUPHAurinia Pharmaceuticals Inc9.58-481.33%
PLXProtalix BioTherapeutics Inc10.89-533.29%
ACADAcadia Pharmaceuticals Inc11.73-566.61%
TBPHTheravance Biopharma Inc12.26-587.84%
ADMAAdma Biologics Inc12.42-594.04%
HRMYHarmony Biosciences Holdings Inc13.82-649.82%
SABSSAB Biotherapeutics Inc14.14-662.39%
NAGENiagen Bioscience Inc14.82-689.52%
INCYIncyte Corp15.82-729.48%
REGNRegeneron Pharmaceuticals Inc15.86-730.84%
PBYIPuma Biotechnology Inc17.32-788.89%
CPRXCatalyst Pharmaceuticals Inc17.44-793.80%
EXELExelixis Inc17.54-797.73%
TGTXTG Therapeutics Inc18.97-854.54%
MDXGMimedx Group Inc20.55-917.66%
XOMAXOMA Royalty Corp22.87-1010.07%
ARGXArgen X SE24.30-1066.70%
CTMXCytomX Therapeutics Inc24.82-1087.51%
XOMAOXOMA Royalty Corp25.34-1108.34%
HALOHalozyme Therapeutics Inc25.62-1119.44%
XOMAPXOMA Royalty Corp25.67-1121.29%
VRTXVertex Pharmaceuticals Inc27.99-1213.77%
RPRXRoyalty Pharma plc - Class A28.69-1241.33%
SLNOSoleno Therapeutics Inc29.02-1254.38%
ASNDAscendis Pharma A/S30.09-1296.95%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1608.33%
APLSApellis Pharmaceuticals Inc39.02-1652.46%
BMRNBiomarin Pharmaceutical Inc42.21-1779.40%
KRYSKrystal Biotech Inc45.34-1903.99%
ONCBeiGene Ltd69.54-2866.67%
PHARPharming Group N.V.75.03-3084.89%
TECHBio-Techne Corp101.96-4156.42%
VCELVericel Corp109.92-4473.22%
ALNYAlnylam Pharmaceuticals Inc117.96-4793.25%
GMABGenmab140.29-5681.47%
TLXTelix Pharmaceuticals Ltd162.15-6551.26%
CORTCorcept Therapeutics Inc212.86-8568.54%